IgE to cross‐reactive carbohydrate determinants (CCD) in childhood: Prevalence, risk factors, putative origins

• Published in: Clinical and experimental allergy Vol. 54; no. 3; pp. 195 - 206
• Main Authors: Potapova, Ekaterina, Tripodi, Salvatore, Panetta, Valentina, Dramburg, Stephanie, Bernardini, Roberto, Caffarelli, Carlo, Casani, Antonella, Cervone, Rosa, Chini, Loredana, Comberiati, Pasquale, De Castro, Giovanna, Giudice, Michele Miraglia, Dello Iacono, Iride, Di Rienzo Businco, Andrea, Gallucci, Marcella, Giannetti, Arianna, Moschese, Viviana, Sfika, Ifigenia, Varin, Elena, Asero, Riccardo, Bianchi, Annamaria, Calvani, Mauro, Frediani, Tullio, Macrì, Francesco, Maiello, Nunzia, Paravati, Francesco, Pelosi, Umberto, Peroni, Diego, Pingitore, Giuseppe, Tosca, Mariangela, Zicari, Anna Maria, Ricci, Giampaolo, Reese, Gerald, Grabenhenrich, Linus, Icke, Katja, Grübl, Armin, Müller, Christoph, Zepp, Fred, Schuster, Antje, Wahn, Ulrich, Lau, Susanne, Keil, Thomas, Matricardi, Paolo Maria
• Format: Journal Article
• Language: English
• Published: England Wiley Subscription Services, Inc 01-03-2024
• Subjects: Allergens; allergens and epitopes; allergic rhinitis; Allergies; CCD; Chemiluminescence; Children; grass pollen; IgE; Immunoglobulin E; Microparticles; pediatrics; Pollen; Risk factors; Streptavidin; allergens and epitopes; allergic rhinitis; CCD; grass pollen; IgE; pediatrics
• ISSN: 0954-7894; 1365-2222
• DOI: 10.1111/cea.14439

Background
IgE antibodies to cross‐reactive carbohydrate determinants (CCD) are usually clinically irrelevant but they can be a cause of false positive outcomes of allergen‐specific IgE tests in vitro. Their prevalence and levels have been so far cross‐sectionally examined among adult allergic patients and much less is known about their origins and relevance in childhood.
Methods
We examined CCD with a cross‐sectional approach in 1263 Italian pollen allergic children (Panallergen in Paediatrics, PAN‐PED), as well as with a longitudinal approach in 612 German children (Multicenter Allergy Study, MAS), whose cutaneous and IgE sensitization profile to a broad panel of allergen extracts and molecules was already known. The presence and levels of IgE to CCD were examined in the sera of both cohorts using bromelain (MUXF3) as reagent and a novel chemiluminescence detection system, operating in a solid phase of fluorescently labelled and streptavidin‐coated paramagnetic microparticles (NOVEOS, HYCOR, USA).
Results
IgE to CCD was found in 22% of the Italian pollen allergic children, mainly in association with an IgE response to grass pollen. Children with IgE to CCD had higher total IgE levels and were sensitized to more allergenic molecules of Phleum pratense than those with no IgE to CCD. Among participants of the German MAS birth cohort study, IgE to CCD emerged early in life (even at pre‐school age), with IgE sensitization to group 1 and 4 allergen molecules of grasses, and almost invariably persisted over the full observation period.
Conclusions
Our results contribute to dissect the immunological origins, onset, evolution and risk factors of CCD‐sIgE response in childhood, and raise the hypothesis that group 1 and/or 4 allergen molecules of grass pollen are major inducers of these antibodies through an antigen‐specific, T‐B cell cognate interaction.
Graphical :
IgE antibodies to CCD in childhood, tested in the PAN‐PED (cross‐sectional approach) and MAS (longitudinal approach) cohorts, are as follows: (1) very frequent in patients with pollen allergy (22%, 275/1263), (2) associated with strong and broad IgE response to grass pollen, (3) emerging with IgE sensitization to grass group 1 and 4 allergens, (4) can start very early in life (positive IgE seen in second year of life) and (5) once started, are almost invariably persistent.